Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks Jan 3 08:05 ET

Jefferies Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsJan 2 10:32 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target

BenzingaJan 2 09:21 ET

Wells Fargo Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating, Cuts Target Price to $2

Moomoo NewsJan 2 07:32 ET · Ratings

Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership -- Barrons.com

Barron'sJan 2 07:03 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaDec 31 16:05 ET